SCIENTIFIC PROGRAM
Thursday - May 17
Session: epidemiology, subtypes, regional issues
Issues about testing for HIV infection in pregnant women
Gabriela Elena Iliescu
County Emergency Clinical Hospital Craiova
14:15-15:15
Survival of HIV infected patients treated with HAART in a resourcelimited setting: the belgrade cohort study
Djordje Jevtovic
Institute of Infective and Tropical Disease Dr Kosta Todorovic, School
of Medicine, University of Belgrade, Belgrade, Serbia
HIV/AIDS infection in the Republic of Moldova
Ina Bîstrițchi
State University of Medicine and Pharmacy "N.Testemitanu", Center
for Health Policies and Studies
Antiretroviral treatment at pregnant women: effects on newborns
Mariana Mărdărescu
National Institute for Infectious Diseases "Prof. Dr. Matei Bals",
Bucharest
15:15-15:30
Short presentation NovaIntermed
15:30-16:00
Keynote lecture: François Simon, MD
Biological and Clinical Consequences of the HIV Diversity
16:00-16:15
Coffee break
16:15-17:15
Symposium Brystol-Myers Squibb:
The Challenge of Achiving Long Time Undetectable Viremia
Chairman: Adrian Streinu-Cercel, MD, PhD
- Current HIV guidelines and perspecives, Irina Dumitru
- HIV and chronic inflamation, Adrian Streinu-Cercel
- Achiving Long Time Undetectable Viremia, Carmen Dorobăț
17:15-17:30
Official opening:
Adrian Streinu-Cercel, MD, PhD
17:30-18:00
Keynote lecture: Douglas Richman, MD
The Challenge of Eradicating the Latent HIV Reservoir
18:00-19:00
Symposium Janssen:
NNRTI Resistance and Rational use of New NNRTIs
Chairman: Adrian Streinu-Cercel, MD, PhD
20:00
Welcome Cocktail
Friday - May 18
09:00-09:30
Keynote lecture: Annemarie Wensing, MD, PhD
HIV Tropism: Impact on Pathogenesis and Clinical Management
Session: resistance, tropism
Deep sequencing to detect minority resistance mutations in patients
with suboptimal adherence
Simona Paraschiv
Molecular Diagnostics, Matei Bals National Institute for Infectious
Diseases, Bucharest, Romania
The prevalence and patterns of genotypic resistance to antiretroviral
drugs in patients with virological failure from Croatia; 2008-2010
Ana Planinic
University Hospital for Infectious Diseases "dr. Fran Mihaljevic",
Zagreb, Croatia. Department for molecular diagnostics and flow
citometry
09:30-10:30
Ten years survey of HIV-1 genetic diversity in Serbia
Marina Siljic
University of Belgrade Faculty of Medicine
Decreasing prevalence of antiretroviral resistance mutations in
Romania HIV patients
Florea Dragos
Prof Dr Matei Bals National Institute for Infectious Diseases, Romania
Analyze of available treatment options in a group of multiexperienced
patients with parenterally-aquired HIV-infection
Roxana Radoi
Dr. Victor Babes Hospital for Infectious and Tropical Diseases,
Bucharest, Romania
10:30-10:45
Coffee break
10:45-11:45
Symposium GlaxoSmithKline:
Managing ARVs between Initiation and Switch
- The role of newer third agents in HIV treatment - Mike Youle, HIV
Research Royal Free Centre for HIV Medicine, London, UK
- HLA 5701 testing in newly diagnosed patients - Dan Otelea, Prof Dr
Matei Bals National Institute for Infectious Diseases, Romania
11:45-12:15
Keynote lecture: Mike Youle, MD, ChB
Co-morbidities and How to Deal with Them
12:15-13:00
Symposium Teva Pharmaceuticals:
New Challenges in Combating IFI in 2012
- Combating IFI with ABELCET 9amphotericin B lipid complex) –
CLEAR registry data, efficacy and safety data
Adrian Streinu-Cercel, MD, PhD, Prof Dr Matei Bals National Institute
for Infectious Diseases, Romania
- Using ABELCET in pediatric population – different challenges, clinical
and safety data
Anca Streinu-Cercel, MD, PhD, Prof Dr Matei Bals National Institute
for Infectious Diseases, Romania
13:00-14:00
Lunch
14:00-14:30
Symposium Boehringer Ingelheim:
Nevirapine Reloaded
Chairman: Adrian Streinu-Cercel, MD, PhD
14:30-15:30
Session: Comorbidities: infectious
Anal HPV infection in HIV-positive and HIV-negative men who have
sex with men in Slovenia
Poljak Mario
Institute of Microbiology and Immunology, Faculty of Medicine,
University of Ljubljana, Slovenia
Tuberculous meningitis in HIV-infected patients
Adriana Hristea
Prof. Dr. Matei Bals National Institute for Infectious Diseases
Low prevalence of hepatitis C infection among HIV-infected
individuals in Slovenia: a nation-wide study, 1986-2011
Seme Katja
Institute of Microbiology and Immunology, Faculty of Medicine,
University of Ljubljana, Slovenia
TB in HIV positive adolescents and adults
Simona Claudia Cambrea
Infectious Diseases Clinic, Faculty of Medicine, "Ovidius" University
15:30-16:30
Symposium Merck Sharp & Dohme:
Treating HIV now for longterm benefits
- Comorbidities in HIV. Choosing the right treatment for the right
patient
Mark Nelson, Chelsea and Westminster Hospital, London, UK
- Longterm benefits of adherence
Odette Chirila, Prof Dr Matei Bals National Institute for Infectious
Diseases, Romania
16:30-16:45
Coffee break
16:45-17:15
Keynote lecture: Mark Wainberg, PhD
Hot Issues in Drug Resistance
Session: Comorbidities: non-infectious
Serum adiponectin and insulin resistance in a cohort of HIV-1 positive
patients undergoing antiretroviral therapy
Catalin Tiliscan
Carol Davila University of Medicine and Pharmacy, Bucharest, Prof.
Dr. Matei Bals National Institute of Infectious Diseases, Bucharest
Metabolic syndrome in HIV infected patients: effects of antiretroviral
therapy
Gordana Dragovic
Institute of Pharmacology, Clinical Pharmacology and Toxicology,
School of Medicine, University of Belgrade, Belgrade, Serbia
17:15-18:15
Adipocytokines profile in HIV treatment-experienced patients with
lipodystrophy syndrome
Daniela Munteanu
Matei Bals National Institute of Infectious Diseases, Bucharest
Effects of adherence on the immunovirological and metabolic profile
of HIV positive patients
Incze Andrea
Infectious Diseases Clinic Tg. Mures, UMPh Tg. Mures
Dyslipidemia in young adults horizontally infected with HIV-1 during
infancy
Augustin Cupșa
University of Medicine and Pharmacy from Craiova, Romania
18:15-19:15
Symposium Roche:
HIV/AIDS Therapy - a successuful strategy
Chairman: Adrian Streinu-Cercel, MD, PhD
20:00
Gala Dinner
Saturday- May 19
08:00-09:00
Clinical Cases Workshop:
Scott Letendre MD, PhD
Ronald Ellis MD, PhD
Cristian Achim MD, PhD
Dan Duiculescu MD, PhD
Lumința Ene MD
09:00-09:30
Symposium Abbott Laboratories:
Evolution and dynamics of HIV-1 infection in the brain
Dan Duiculescu MD, PhD
09:30-10:00
Keynote lecture: Scott Letendre, MD, PhD
HIV Associated Neurocognitive Disorders
10:00-10:15
Keynote lecture: Luminița Ene, MD
Discussion on the evaluation algorithm of HIV associated
complications in Romania
10:15-10:30
Q&A
10:30-10:45
Coffee break
10:45-11:15
Keynote lecture: Cristian Achim, MD, PhD
Clinical-pathological Correlations in HIV-associated Neurocognitive
Disorders
11:15-11:45
Keynote lecture: Ronald Ellis, MD, PhD
HIV Related Peripheral Nervous System Disorders
11:45-12:00
Q&A
Session: NeuroHIV
Screening of neurocognitive disorders on HIV patients
Arbune Manuela
"Dunarea de Jos" University Galati
12:00-12:45
Considerations about risk factors encountered in romanian HIVinfected patients diagnosed with symptomatic peripheral
neuropathies
Giubelan Lucian
University of Medicine and Pharmacy from Craiova, Romania
Pluri-microbial aggression in CNS in HIV patients? Kibitzer or
responsible? 5 case-reports
Ruxandra Moroti
The National Institute for Infectious Diseases Prof. Dr. Matei Bals,
Bucharest
12:45-13:00
Closing remarks:
Adrian Streinu-Cercel, MD, PhD